Schroder Investment Management Group Spring Works Therapeutics, Inc. Transaction History
Schroder Investment Management Group
- $94.4 Billion
- Q1 2025
A detailed history of Schroder Investment Management Group transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 599,893 shares of SWTX stock, worth $28.2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
599,893
Previous 168,209
256.64%
Holding current value
$28.2 Million
Previous $6.08 Million
335.63%
% of portfolio
0.03%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding SWTX
# of Institutions
335Shares Held
62.3MCall Options Held
6.12MPut Options Held
2.55M-
Vanguard Group Inc Valley Forge, PA7.08MShares$333 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$264 Million0.0% of portfolio
-
State Street Corp Boston, MA2.92MShares$137 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.58MShares$121 Million0.01% of portfolio
-
Woodline Partners LP San Francisco, CA2.14MShares$101 Million0.66% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.93B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...